ABSTRACT-Effects of a new antiulcer drug, MCI-727, on gastric and duodenal lesions, gastric secretion and gastric motility were studied in comparison with cimetidine and teprenone. MCI-727 dose-dependently (3-100 mg/kg, p.o. or i.d.) inhibited the development of acute gastric or duodenal lesions such as pyrolus ligation-, waterimmersion stress-, indomethacin-, HCl-, HCl-ethanol-induced gastric lesions and cysteamine-induced duodenal lesions in rats and histamine-induced duodenal lesions in guinea pigs. These antiulcer effects exceeded those of cimetidine or teprenone. Repeated administration of MCI-727 (0.3-3 mg/kg/day, p.o., for 10 days) significantly promoted the spontaneous healing of acetic acid-induced chronic gastric ulcers. Concerning gastric acid secretion, MCI-727 selectively inhibited tetragastrin-stimulated acid secretion without effecting basal acid secretion and acid secretion by other stimuli. Cimetidine and teprenone inhibited acid secretion in several cases. MCI-727 and teprenone had inhibitory effects on gastric motility, although cimetidine had no effect. These results suggest that MCI-727 has a wide spectrum of antiulcer activity, and its mode of antiulcer action is different from that of cimetidine or teprenone.
After the development of the histamine H2-receptor blocker cimetidine, antiulcer therapeutics has progressed rapidly. However, refinements are still required, because some problems, such as recurrence of ulcer, remain to be solved. In our laboratory, we have attempted to develop new antiulcer agents by synthesizing a number of aryl ethanoneoxim derivatives and evaluating their efficacy on some experimental ulcer models. Among the active compounds, MCI-727 ((Z)-2-(4-methylpiperazin-1-yl)-1-4-(2-phenyl-ethyl) phenylethanone oxime hydrochloride monohydrate) ( Fig. 1 ) was selected for further pharmacological evaluation as the most promising one with low toxicity. In the present study, we determined the effects of MCI-727 on experimental gastric or duodenal ulcer models. We also examined its effects on gastric secretion and motility to obtain information on the mechanism of its antiulcer action. In addition, the effects of MCI-727 were compared with those of teprenone, which has been reported to have antiulcer effects by enhancing the mucus and mucosal barrier (1) , and the histamine Hz-receptor blocker cimetidine.
MATERIALS AND METHODS

Experimental animals
Male Donryu rats (200-250 g, Japan SLC), female Wistar rats (180-230 g, Japan Laboratory Animals) and male Hartley guinea pigs (300-350g, Japan Laboratory Animals) were used in the experiments.
Experimental materials
MCI-727 ((Z)-2-(4-methylpiperazin-l-yl)-1-4-(2-phenyl-ethyl) phenyl-ethanone oxime hydrochloride monohydrate) was synthesized in the Pharmaceuticals Laboratory, Research Center, Mitsubishi Kasei Corporation. Other drugs used in the experiments were cimetidine (Sogoyakkou), teprenone (Eisai), indomethacin, tripelennamine, histamine dihydrochloride, cysteamine hydrochloride, 2-deoxy-D-glucose (Sigma), Gum. Arab., ethanol (Junsei Chemical), Tween 80, hydrochloric acid (Nacalai Tesque), acetic acid (Kishida Chemical), ether (Showa Ether), sodium pentobarbital (Pitman-Moore), and tetragastrin (Sana).
In the experiments, MCI-727 and cimetidine were suspended in 2.5% gum arabic solution, and teprenone was suspended in a trace amount of Tween 80 solution. Each test drug, vehicle, or ulcerogenic agent was given in a volume of 0.2 ml/100 g body wt.
Experimental ulcer
Water-immersion stress-induced gastric erosions: Male Donryu rats, not fasted before experiments, were placed in a restraint cage (Natsume) and then immersed vertically to the level of the xiphoid process in a water bath (23 ± 1°C) (2, 3) . Sixteen hours later, the animals were killed, and the stomach of each rat was removed and inflated by injecting 12 ml of 1% formalin to fix the inner and outer layers of the gastric wall. This formalin treatment was performed in all the following experiments. Subsequently, the stomach was incised along the greater curvature and examined for erosions in the glandular portion. Each drug or vehicle alone was given p.o. 30 min before stressing.
Shay's ulcers: Male Donryu rats were deprived of food but allowed free access to water for 48 hr prior to experiments. Under ether anesthesia, the abdomen was incised and the pylorus ligated (4). Eighteen hours later, the animals were killed, and the stomach was examined for ulcers in the forestomach. Each drug or vehicle alone was given i.d. immediately after pylorus ligation.
Indomethacin-induced gastric erosions: Male Donryu rats were deprived of food but allowed free access to water for 24 hr, and then indomethacin at 40 mg/kg, suspended in 0.5% Tween 80, was given p.o. (5) . The animals were killed 6 hr later, and the stomach was examined for erosions in the glandular portion. Each drug or vehicle alone was given p.o. 30 min before indomethacin treatment.
HCl-induced gastric erosions: Male Wistar rats were deprived of food and water for 24 hr, and then 1 ml of 0.6 N HC1 was given p.o. (6) . The animals were killed 1 hr later, and the stomach was examined for erosions in the glandular portion. Each drug or vehicle alone was given p.o. 30 min before 0.6 N HCl treatment.
HCl-ethanol-induced gastric erosions: Male Donryu rats were deprived of food and water for 24 hr, and then 1 ml of HCl-ethanol (35% HC1 : 99.5% ethanol = 1 : 50) was given p.o. The animals were killed 1 hr later, and the stomach was examined for erosions in the glandular portion. Each drug or vehicle alone was given p.o. 30 min before HCl-ethanol treatment.
Cysteamine-induced duodenal ulcers: Female Wistar rats were deprived of food but allowed free access to water for 24 hr, and then cysteamine hydrochloride (350 mg/kg), dissolved in saline, was given s.c. (7) . The animals were killed 22 hr later, and the duodenum were examined for duodenal ulcers. Each drug or vehicle alone was given p.o. 30 min before cysteamine treatment.
Histamine-induced duodenal ulcers: Male Hartley guinea pigs were deprived of food but allowed free access to water for 24 hr, and then histamine dihydrochloride (0.15 mg/kg), dissolved in saline, was given i.m. eight times, at 30-min intervals (8) . Thirty min after the final administration the animals were killed, and the duodenum was examined for duodenal lesions. Each drug or vehicle alone was given p.o. 10 min before histamine treatment.
Acetic acid-induced ulcers: Male Donryu rats, deprived of food but allowed free access to water for 24 hr, were used. Under pentobarbital (35 mg/kg, i) p.) anesthesia, the abdomen was incised and the anterior portion of the stomach was exposed. Then 0.05 ml of 20% acetic acid (v/v) was injected into the submucosal layer in the antrum (9) . After closure of the abdomen, the animals were maintained on rat chow and water ad libitum thereafter. Each drug or vehicle alone was given p.o. once daily (1:00 P.M.) starting from the third day after the operation for 10 days. The animals were killed 22 hr after the final administration of drugs or vehicle, and the stomach was examined for ulcers.
Duration of antiulcer action: The duration of the antiulcer action of drugs was tested in the gastric lesion model induced by HCI-ethanol. HCl-ethanol was administered at various time intervals from 30 min to 16 hr, after oral treatment with drugs. The other procedures were the same as described in the method about HCl-ethanol -induced gastric erosions.
Lesion index: For the lesion index or ulcer index, the total length (mm) of erosions induced by water-immersion stress, indomethacin, HCI, HCl-ethanol, histamine and the area (mm2) of each ulcer induced by cysteamine and acetic acid were measured under a dissecting microscope (X 10). Each area (mm2) of damaged forestomach in Shay's ulcers was measured under a dissecting microscope (X 10), summed, and arbitrarily classified into five degrees by an ulcer index as follows (10): Gastric secretory studies Male Donryu rats, which were deprived of food but allowed free access to water for 24 hr, were used. Effects on gastric basal secretion were studied in pylorus ligated rats. Under ether anesthesia, the abdomen was incised and the pylorus ligated. Five hours after pylorus ligation, the animals were given an overdose of ether and the gastric contents were collected and analyzed for volume, acidity, and pepsin activity. Acidity was determined by automatic titration of gastric juice against 0.01 N NaOH to pH 7 (Autoburette and autotitrator, Radiometer, Copenhagen). Pepsin activity was determined by Anson's method using hemoglobin as a substrate (11) . Titratable acid and pepsin output were expressed as u Eq/5 hr and mg tyrosin/5 hr, respectively. Each drug or vehicle alone was given i.d. immediately after pylorus ligation.
Effects on stimulated gastric acid secretion were studied in acute gastric fistula rats (12) . Under ether anesthesia, the abdomen was incised and a gastric fistula made by a polyethylene tube was attached in the fundic portion after ligation of the pyloric portion. After recovery from anesthesia, rats were fixed in a stainless steel cage, and gastric juice was collected every hour. The volume and acidity of the gastric juice were analyzed as described above. To stimulate gastric secretion, tetragastrin (200,ug/kg/hr), histamine dihydrochloride (8 mg/kg/hr), and 2-deoxy-Dglucose (200 mg/kg/hr) were infused from the tail vein after recovery from anesthesia. Each drug or vehicle alone was given L d. via a duodenal catheter 1 hr before initiation of stimuli infusion.
Gastric motility studies
Male Donryu rats were deprived of food but allowed free access to water for 24 hr prior to the experiment. Gastric motility were measured in conscious normal rats using a miniature balloon method as described by Takeuchi and Nobuhara (13) . Briefly, under ether anesthesia, the balloon (5 mm in diameter) and the support catheter were inserted into the stomach through a cautery hole in the greater curvature of the forestomach about 5 mm from the limiting ridge. They were tied in place so that they lay in the glandular part of the stomach. The balloon and catheter system was connected to a pressure transducer (LPU-0.1, Toyo Baldowin) and polygraph (NEC San-ei). The incision was then closed with a ligature, and the rats were placed on their right side in a stainless cage with a longitudinal slit at the bottom. Then the internal pressure of the balloon was recorded. The gastric motility index was expressed by maximal intra-gastric pressure in each 10 min period. Each drug was given i.d. 1 hr after recovery from ether anesthesia by means of a catheter inserted into the duodenum. In the indomethacin pretreatment study, indomethacin (40 mg/kg, p.o.) was given to the animals 5 hr before ether anesthesia, and the other procedures were the same as in the normal rat study.
Analysis of data
Data are expressed as the mean ± S.E. Student's t-test was used to determine the statistical significance of data, and P < 0.05 (indicated by * in the figures or tables) was regarded as significant.
RESULTS
Effects on various acute gastric ulcers or erosions Water-immersion stress, indomethacin, HCI, and HCl-ethanol produced multiple, band-like or elongated erosions in the glandular stomach, and pylorus ligation produced multiple ulcers or perforation in the forestomach. The incidence of the lesions of control animals was 100% in every model. MCI-727 dose-dependently inhibited the development of the gastric mucosal lesions in these models (Table 1) . On indomethacin-and HCl-ethanol-induced erosions, the effects were significant at the lowest dose of 10 mg/kg. With doses of 30 and 100 mg/kg, it also significantly inhibited the development of other gastric erosions. The inhibition rate at 30 mg/kg was 32.9%, 50.7%, 66.4%, 64.5% and 94.1% for water-immersion stress-, Shay's, indomethacin-, HCl and HC1-ethanol-induced lesions, respectively. Cimetidine (100 mg/kg) inhibited indomethacin-and Effects on duodenal lesions Cysteamine produced one or two penetrating ulcers in the rat proximal duodenum, the incidence being more than 90%. On the other hand, histamine produced multiple elongated lesions in the guinea pig duodenum, the incidence being 100%. As shown in Table 2 , MCI-727 inhibited the development of cysteamine-and histamine-induced duodenal ulcers at 100 mg/kg; the inhibition rate was 55.5% and 52.6%, respectively. Cimetidine (100 mg/kg) also inhibited both duodenal lesions; the inhibition rate was 84.3% and 76.2% for cysteamine-and histamine-induced duodenal lesions, respectively. Teprenone (100 mg/kg) failed to inhibit these duodenal lesions. 
Effects on acetic acid-induced ulcers
The submucosal injection of 20% acetic acid produced visible round ulcers (50-60 MM2) in the stomach by the third day after injection. Thirteen days after injection, the mean ulcerated area in the control animals was 10-15 mm 2. As shown in Fig. 2 , once daily administration of MCI-727 (0.3, 1 and 3 mg/kg) significantly accelerated the healing of the ulcers: the healing rate was 47.0%, 40.7%, and 37.2%, respectively. On the other hand, once daily administration of cimetidine (200 mg/kg) and teprenone (200 mg/kg) failed to promote the healing of the ulcers.
Duration of antiulcer action
The durations of the antiulcer actions of the drugs on HCl-ethanol induced lesions are shown in Fig. 3 . MCI-727 (30 mg/kg), cimetidine (200 mg/kg) and teprenone (200 mg/kg) produced almost the same inhibition of the lesion index in the 30-min pretreatment schedule. The antiulcer action lasted at least 8 hr in the case of MCI-727. On the other hand, the antiulcer effects of cimetidine and teprenone were observed only when they were administered 30 min before HCl-ethanol treatment. The average values were 3 -5 ml, 250-400 ,uEq and 40-90 mg tyrosine for volume, acid output and pepsin output, respectively. MCI-727 (10-30 mg/kg) and teprenone (100 mg/kg) did not have any effect on basal acid secretion (Table 3) . At 100 mg/kg, MCI-727 tended to inhibit gastric secretion, but the effect was not statistically significant. Cimetidine (100 mg/kg) significantly inhibited acid and pepsin output by 74.7% and 67.4%, respectively.
As for the cases of stimulated gastric acid secretion, MCI-727 (30 mg/kg) inhibited tetragastrin-stimulated gastric acid secretion for 1 hr, without affecting the histamineand 2-deoxy-D-glucose-stimulated gastric acid secretion (Fig. 4) . Cimetidine (100 mg/kg) markedly inhibited acid secretion stimulated by tetragastrin, histamine and 2-deoxy-D-glucose. Teprenone (100 mg/kg) also inhibited acid secretion by all stimuli for 1 hr.
Effects on gastric motility
The motility indexes of normal rats anc indomethacin treated rats were 15 -25 and 50 -70 cmH-?O, respectively. MCI-727 (3-3C mg/kg) dose-dependently inhibited the indomethacin-induced gastric hypermotility (Fig. 5) . Teprenone (100 mg/kg) also suppressed the hypermotility, but cimetidine (10C mg/kg) did not have any effect. In normal rats, MCI-727 suppressed the motility at doses over 10 mg/kg (Fig. 6) . Teprenone (IOC mg/kg) tended to depress the motility of normal rats, but the effect was not statistically significant, whereas cimetidine (100 mg/kg) did not have any effect. ulcer effects of MCI-727 on various types of experimental ulcer models, to predict its possible clinical efficacy on peptic ulcers. As the first step to obtain insight into the pharmacological profiles of MCI-727 as an antiulcer agent, effects of the compound on gastric secretion and gastric motility were also examined. In the experiments described above, the histamine H2-receptor blocker cimetidine, and teprenone, which is classified as an enhancer of defensive factors of the gastric mucosa (1), were used as the reference drug. MCI-727 (3-100 mg/kg, p.o. or i.d.) dosedependently prevented the development of various acute gastric and duodenal lesions (water-immersion stress-, Shay's, indomethacin-, HCl-, HCI-ethanol-induced gastric ulcers or erosions and cysteamine-, histamine-induced duodenal ulcers or lesions). Its antiulcer effects were marked in gastric lesions rather than in duodenal lesions. MCI-727 (0.3-3 mg/kg, p.o.) also promoted the healing of acetic acid-induced gastric ulcers. However its effects were not dose-dependent; and at 10 mg/kg, the effect was not statistically significant. So, there might be an optimal dose of MCI-727 that manifests the beneficial effect on the healing of these chronic ulcers, like what has been reported for arbaprostil (14) . The difference in effective dose between acute and chronic ulcer models may suggest the possibility that the antiulcer activity of MCI-727 was increased by consecutive administration. Cimetidine (100 mg/kg), which inhibits gastric basal acid secretion by 74.7%, also showed antiulcer effects on several gastric or duodenal lesions. This drug, however, showed no effects on Shay's ulcers and HCl-induced erosions, and it failed to promote the healing of acetic acid-induced gastric ulcers. Furthermore, teprenone (100 mg/kg) exhibited antiulcer effects on only two kinds of gastric lesions (indomethacin-and HCl-induced gastric lesions). The duration of the antiulcer action of MCI-727 was also compared with those of cimetidine and teprenone in the HCl-ethanolinduced gastric ulcer model, and it was found to be more than four times longer than those of cimetidine and teprenone. So these differences in the duration of action may influence the antiulcer action of these three drugs, especially in Shay's, water-immersion stress-, acetic acid-induced ulcer models.
From these results on experimental ulcers, it is suggested that the antiulcer effects of MCI-727 are superior to those of cimetidine or teprenone in both potency and antiulcer spectrum.
Concerning the gastric acid secretion, cimetidine (100 mg/kg) inhibited not only the basal acid secretion in pylorus ligated rats, but the acid secretion stimulated by tetragastrin, histamine and 2-deoxy-D-glucose in acute gastric fistula rats. Although not as clearly as cimetidine, teprenone (100 mg/kg) also showed the similar inhibitory propensities on stimulated acid secretion. On the other hand, MCI-727 only inhibited tetragastrin-stimulated acid secretion without any significant effect on other experimental conditions. Little has been reported on drugs that can selectively inhibit acid secretion due to gastrin receptor stimulation except for the case of secretin (15, 16) . Secretin, one of the gastrointestinal hormones, is reported to have antiulcer effects (17, 18) ; and it has been used for peptic ulcer disease. Considering these conditions, participation of endogenous secretin may be postulated as one of the probable mechanisms of the gastrinselective antisecretory action of MCI-727.
In addition to the acid secretion, the role of gastric motility in the pathogenesis of gastric lesions has been reported. For example, Mersereau and Hinchey (19) and Takeuchi et al. (20) suggested that gastric hypermotility might be a major factor in the genesis of gastric lesions induced by indomethacin, by showing the close correlation between the lesion index and the motility index. Similar hypotheses have also been reported in other experimental ulcer models, including water-immersion stress-and various necrotizing agent-induced gastric lesions (13, 21, 22) . Moreover, some antiulcer drugs such as beguhexate•CD and secretin were reported to possess inhibitory effects on gastric motility in normal rats or humans (23) (24) (25) . So, we examined the effects of MCI-727 on the gastric motility under two different conditions: One is gastric motility in normal rats (A), and the other is gastric hypermotility in indomethacin (40 mg/kg, p.o.) pretreated rats (B). MCI-727 depressed the gastric motility in both A and B. The minimal effective dose in A is 10 mg/kg, Ed. and in B, 3 mg/kg, i.d. Teprenone (100 mg/kg, i.d.) also depressed gastric motility in B and showed a tendency of depression in A.
As for cimetidine (100 mg/kg, i.d.), there was no significant effects on the gastric motility. As far as gastric motility is concerned, the effects of MCI-727 resemble those of teprenone, although the potency was much higher in MCI-727. Considering these results and the findings described above, the antiulcer effects of MCI-727 and teprenone may partly depend on the depression of gastric motility.
In summarizing the present results, the pharmacological profiles of MCI-727 may be different from those of cimetidine and teprenone in the sense that only MCI-727 selectively inhibits tetragastrin-stimulated acid secretion and depresses the gastric motility. On the other hand, we have already obtained the preliminary result that the plasma secretin level increased by oral administration of MCI-727 in rats (26) . Taking these results into account, it may well be suggested that secretin will become an important clue for clarifying the precise mechanism for the potent and wide spectrum of the antiulcer effects of MCI-727.
Although the detailed investigations are further required, the present results suggest that MCI-727 may be clinically useful for the treatment of peptic ulcers.
